Fecal, Blood, and Urinary Biomarkers in Inflammatory Bowel Diseases
Journal of Translational Gastroenterology · 28.06.2024 · 2 (2) · 61-75
DOI: 10.14218/jtg.2024.00017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Translational Gastroenterology, online erschienen am 28.06.2024. Verfasst von John W Wiley und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Michigan Medicine, Ann Arbor, MI, USA. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
The brain-gut axis represents a bidirectional communication network that integrates neural, hormonal, and immunological signaling between the central nervous system and the gastrointestinal tract. Adverse childhood experiences (ACEs) have increasingly been recognized for their profound impact on this axis, with implications for both mental and physical health outcomes. This mini-review explores the emerging field of epigenomics-specifically, how epigenetic modifications incurred by ACEs can influence the brain-gut axis and contribute to the pathophysiology of various disorders. We examine the evidence linking epigenetic mechanisms such as DNA methylation, histone modifications, and non-coding RNAs to the modulation of gene expression involved in stress responses, neurodevelopment, and immune function-all of which intersect at the brain-gut axis. Additionally, we discuss the emerging potential of the gut microbiome as both a target and mediator of epigenetic changes, further influencing brain-gut communication in the context of ACEs. The methodological and therapeutic challenges posed by these insights are significant. The reversibility of epigenetic marks and the long-term consequences of early life stress require innovative and comprehensive approaches to intervention. This underscores the need for comprehensive strategies encompassing psychosocial, pharmacological, neuromodulation, and lifestyle interventions tailored to address ACEs' individualized and persistent effects. Future directions call for a multi-disciplinary approach and longitudinal studies to uncover the full extent of ACEs' impact on epigenetic regulation and the brain-gut axis, with the goal of developing targeted therapies to mitigate the long-lasting effects on health.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, University of Michigan Medicine, Ann Arbor, MI, USA.
- Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.
ORCID-Profile: John W Wiley
Förderung
- NIDDK NIH HHS
- NINDS NIH HHS
Zitieren
APA
Wiley, J. W., & Higgins, G. A. (2024). Fecal, Blood, and Urinary Biomarkers in Inflammatory Bowel Diseases. Journal of Translational Gastroenterology, 2(2), 61-75. https://doi.org/10.14218/jtg.2024.00017
Vancouver
Wiley JW, Higgins GA. Fecal, Blood, and Urinary Biomarkers in Inflammatory Bowel Diseases. Journal of Translational Gastroenterology. 2024;2(2):61-75. doi:10.14218/jtg.2024.00017
BibTeX
@article{Wiley2024,
author = {Wiley, John W and Higgins, Gerald A},
title = {Fecal, Blood, and Urinary Biomarkers in Inflammatory Bowel Diseases},
journal = {Journal of Translational Gastroenterology},
year = {2024},
volume = {2},
number = {2},
pages = {61--75},
doi = {10.14218/jtg.2024.00017}
}
EUVIMED